| Literature DB >> 23099129 |
Maryann C Deak1, John W Winkelman.
Abstract
Insomnia is a common disorder, with individual and societal consequences. Advances have been made in the understanding of insomnia and its treatment options. However, cognitive behavioral therapy and Food and Drug Administration-approved pharmacologic therapies have limitations, the former primarily involving access and the latter involving potential side effects. Further research is needed to optimize management strategies.Entities:
Mesh:
Year: 2012 PMID: 23099129 DOI: 10.1016/j.ncl.2012.08.012
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806